Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Chisato Yoshijima"'
Autor:
Chisato Yoshijima, Yosuke Suzuki, Ryota Tanaka, Hiroyuki Ono, Ayako Oda, Takashi Ozaki, Hirotaka Shibata, Hiroki Itoh, Keiko Ohno
Publikováno v:
Pharmacology Research & Perspectives, Vol 12, Iss 4, Pp n/a-n/a (2024)
Abstract In this study, plasma belimumab concentrations were measured over the course of treatment in systemic lupus erythematosus (SLE) patients on belimumab therapy, and intra‐ and interindividual variations in plasma belimumab concentration were
Externí odkaz:
https://doaj.org/article/110f7349bae04c588147b1235d8b168a
Autor:
Chisato Yoshijima, BSPharm, Yosuke Suzuki, PhD, Ayako Oda, BSPharm, Ryota Tanaka, PhD, Hiroyuki Ono, BSPharm, Hiroki Itoh, PhD, Keiko Ohno, PhD
Publikováno v:
Current Therapeutic Research, Vol 100, Iss , Pp 100738- (2024)
Background: Belimumab is the first antibody drug approved for systemic lupus erythematosus (SLE), and is a fully human monoclonal antibody that inhibits soluble B lymphocyte stimulator protein. In clinical trials, a composite index was used to assess
Externí odkaz:
https://doaj.org/article/5b77d26f5f1a49c2b8ef205c4172a692
Autor:
Yosuke Suzuki, Yuri Sasamoto, Teruhide Koyama, Chisato Yoshijima, Ayako Oda, Masahiro Nakatochi, Michiaki Kubo, Yukihide Momozawa, Ritei Uehara, Keiko Ohno
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 4, Pp 1403-1411 (2021)
Abstract Plasma coproporphyrin‐I (CP‐I) concentration is used as a sensitive and selective endogenous probe for phenotyping organic anion transporting polypeptides 1B (OATP1B) activity in many studies. CP‐I is produced in the process of heme sy
Externí odkaz:
https://doaj.org/article/8c1144d92f4a45bf802b3b712435c646
Autor:
Yosuke Suzuki, Yuri Sasamoto, Teruhide Koyama, Chisato Yoshijima, Masahiro Nakatochi, Michiaki Kubo, Yukihide Momozawa, Ritei Uehara, Keiko Ohno
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 1, Pp 382-388 (2021)
Coproporphyrin‐I (CP‐I) in plasma is a sensitive and specific endogenous probe for phenotyping organic anion transporting polypeptides 1B (OATP1B, encoded by SLCO1B). A few small‐scale studies suggested that plasma CP‐I concentration is affec
Externí odkaz:
https://doaj.org/article/405c38a7b41543be87c2ab5c79a7e63f
Autor:
Takuma Watanabe, Ryota Tanaka, Yosuke Suzuki, Haruki Sato, Jun Negami, Chisato Yoshijima, Ayako Oda, Hiroyuki Ono, Ryosuke Tatsuta, Keiko Ohno, Hiroki Itoh
Publikováno v:
British journal of clinical pharmacologyREFERENCES.
Cyclosporin A (CyA) has potent inhibitory activity on organic anion transporting polypeptide 1B (OATP1B), causing drug-drug interactions with its substrate drugs. 3-carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF), a uraemic toxin, has also been su
Autor:
Masahiro Nakatochi, Michiaki Kubo, Keiko Ohno, Teruhide Koyama, Ayako Oda, Chisato Yoshijima, Ritei Uehara, Yukihide Momozawa, Yosuke Suzuki, Yuri Sasamoto
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 14, Iss 4, Pp 1403-1411 (2021)
Clinical and Translational Science, Vol 14, Iss 4, Pp 1403-1411 (2021)
Plasma coproporphyrin‐I (CP‐I) concentration is used as a sensitive and selective endogenous probe for phenotyping organic anion transporting polypeptides 1B (OATP1B) activity in many studies. CP‐I is produced in the process of heme synthesis,
Autor:
Yuri Sasamoto, Masahiro Nakatochi, Keiko Ohno, Yukihide Momozawa, Chisato Yoshijima, Yosuke Suzuki, Ritei Uehara, Teruhide Koyama, Michiaki Kubo
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 1, Pp 382-388 (2021)
Clinical and Translational Science
Clinical and Translational Science
Coproporphyrin‐I (CP‐I) in plasma is a sensitive and specific endogenous probe for phenotyping organic anion transporting polypeptides 1B (OATP1B, encoded by SLCO1B). A few small‐scale studies suggested that plasma CP‐I concentration is affec
Autor:
Hiroyuki Ono, Chisato Yoshijima, Hiroki Itoh, Hiromitsu Mimata, Yuri Sasamoto, Ryota Tanaka, Yosuke Suzuki, Tadasuke Ando, Toshitaka Shin, Keiko Ohno
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 184
In chronic kidney disease (CKD), organic anion transporting polypeptide (OATP)1B activity is reduced by mechanisms involving 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF), a uremic toxin. Coproporphyrin-I (CP-I) is a sensitive and specific
Autor:
Yoshijima, Chisato1, Suzuki, Yosuke1 y‐suzuki@my‐pharm.ac.jp, Tanaka, Ryota2, Ono, Hiroyuki2, Oda, Ayako1, Ozaki, Takashi3, Shibata, Hirotaka3, Itoh, Hiroki2, Ohno, Keiko1
Publikováno v:
Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-7. 7p.
Autor:
Suzuki, Yosuke1 (AUTHOR) y-suzuki@my-pharm.ac.jp, Sasamoto, Yuri1 (AUTHOR), Koyama, Teruhide2 (AUTHOR), Yoshijima, Chisato1 (AUTHOR), Oda, Ayako1 (AUTHOR), Nakatochi, Masahiro3 (AUTHOR), Kubo, Michiaki4 (AUTHOR), Momozawa, Yukihide4 (AUTHOR), Uehara, Ritei2 (AUTHOR), Ohno, Keiko1 (AUTHOR)
Publikováno v:
CTS: Clinical & Translational Science. Jul2021, Vol. 14 Issue 4, p1403-1411. 9p.